DA
DCM Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $767K | Buy |
31,659
+5,203
| +20% | +$126K | 0.33% | 35 |
|
|
2025
Q1 | $669K | Sell |
26,456
-3,661
| -12% | -$92.6K | 0.36% | 34 |
|
|
2024
Q4 | $799K | Buy |
30,117
+5,461
| +22% | +$145K | 0.37% | 34 |
|
|
2024
Q3 | $714K | Hold |
24,656
| – | – | 0.36% | 39 |
|
|
2024
Q2 | $690K | Sell |
24,656
-83,472
| -77% | -$2.34M | 0.36% | 39 |
|
|
2024
Q1 | $3M | Buy |
108,128
+249
| +0.2% | +$6.91K | 1.24% | 27 |
|
|
2023
Q4 | $3.11M | Buy |
107,879
+47,358
| +78% | +$1.36M | 1.11% | 30 |
|
|
2023
Q3 | $2.01M | Sell |
60,521
-35
| -0.1% | -$1.16K | 0.91% | 33 |
|
|
2023
Q2 | $2.22M | Sell |
60,556
-39
| -0.1% | -$1.43K | 0.95% | 33 |
|
|
2023
Q1 | $2.47M | Sell |
60,595
-384
| -0.6% | -$15.7K | 1.15% | 29 |
|
|
2022
Q4 | $3.12M | Buy |
60,979
+31,933
| +110% | +$1.64M | 1.52% | 26 |
|
|
2022
Q3 | $1.27M | Sell |
29,046
-8,239
| -22% | -$361K | 0.64% | 41 |
|
|
2022
Q2 | $1.96M | Buy |
37,285
+3,192
| +9% | +$167K | 0.84% | 30 |
|
|
2022
Q1 | $1.77M | Sell |
34,093
-3,002
| -8% | -$155K | 0.62% | 42 |
|
|
2021
Q4 | $2.19M | Buy |
37,095
+12,278
| +49% | +$725K | 0.65% | 37 |
|
|
2021
Q3 | $1.07M | Buy |
+24,817
| New | +$1.07M | 0.41% | 71 |
|